Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

CHRNA9 anticorps (N-Term)

CHRNA9 Reactivité: Humain WB Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN2796324
  • Antigène Voir toutes CHRNA9 Anticorps
    CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
    Épitope
    • 5
    • 2
    • 2
    • 1
    • 1
    AA 8-42, N-Term
    Reactivité
    • 12
    • 6
    • 4
    • 3
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 12
    • 1
    Lapin
    Clonalité
    • 12
    • 1
    Polyclonal
    Conjugué
    • 13
    Cet anticorp CHRNA9 est non-conjugé
    Application
    • 13
    • 6
    • 4
    • 2
    • 2
    Western Blotting (WB)
    Fonction
    Rabbit Anti-Human CHRNA9 (N-term) Antibody
    Immunogène
    This CHRNA9 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 8-42 amino acids from the N-terminal region of human CHRNA9.
    Isotype
    Ig Fraction
    Top Product
    Discover our top product CHRNA9 Anticorps primaire
  • Indications d'application
    Western Blot
    Recommended Dilutions
    WB: 1:1000Western blot analysis of lysate from Daudi cell line, using CHRNA9 Antibody (N-term) at 1:5000 dilution was used as the secondary antibody. Lysate at 35 μg.
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    0.5 mg/mL
    Stock
    4 °C,-20 °C
    Stockage commentaire
    2-8°C (short-term), -20°C (long-term)
  • Antigène
    CHRNA9 (Cholinergic Receptor, Nicotinic, alpha 9 (Neuronal) (CHRNA9))
    Autre désignation
    CHRNA9 (CHRNA9 Produits)
    Synonymes
    anticorps HSA243342, anticorps NACHRA9, anticorps 2410015I05Rik, anticorps Acra9, anticorps EG666827, anticorps Gm8311, anticorps cholinergic receptor nicotinic alpha 9 subunit, anticorps cholinergic receptor, nicotinic, alpha polypeptide 9, anticorps CHRNA9, anticorps Chrna9
    Sujet

    Target Description: Ionotropic receptor with a probable role in the modulation of auditory stimuli. Agonist binding may induce an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. The channel is permeable to a range of divalent cations including calcium, the influx of which may activate a potassium current which hyperpolarizes the cell membrane. In the ear, this may lead to a reduction in basilar membrane motion, altering the activity of auditory nerve fibers and reducing the range of dynamic hearing. This may protect against acoustic trauma. May also regulate keratinocyte adhesion.

    Gene Symbol: CHRNA9

    Poids moléculaire
    54807 Da
    ID gène
    55584
    UniProt
    Q9UGM1
    Pathways
    Sensory Perception of Sound
Vous êtes ici:
Support technique